Comparison of inflammatory biomarkers between diabetic and non-diabetic patients with unstable angina

Marçal de Oliveira Huoya1, Rafaela Andrade Penalva, Sílber Rodrigues Alves

  • 1Divisão de Cardiologia, Hospital Santa Izabel, Salvador, Brazil. mohuoya@cardiol.br

Insights

Diabetic and non-diabetic patients with unstable angina show similar inflammatory activity, suggesting acute-phase protein increase is independent of metabolic state. This challenges the notion that inflammation drives worse outcomes in diabetic patients with this condition.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Limited research exists on inflammatory differences between diabetic and non-diabetic individuals with acute coronary syndrome.
  • No prior studies have specifically compared inflammation in unstable angina (UA) patients with and without diabetes.

Purpose of the Study:

  • To compare serum C-reactive protein (CRP) and interleukin-6 (IL-6) levels in diabetic versus non-diabetic UA patients.
  • To investigate if inflammatory differences explain poorer prognosis in diabetic UA patients.
  • To assess correlations between inflammatory markers, metabolic profiles, and in-hospital outcomes in diabetic UA patients.

Main Methods:

  • A prospective cohort study involving 90 consecutive UA patients.
  • Patients were categorized into diabetic and non-diabetic groups.
  • Serum CRP, IL-6, leukocyte count, and metabolic profiles were measured upon hospital admission.

Main Results:

  • No significant differences in median CRP or IL-6 levels were observed between diabetic and non-diabetic UA patients.
  • Positive correlations were found between CRP and total cholesterol, LDL-cholesterol, and leukocyte count in both groups.
  • No associations were identified between inflammatory markers and in-hospital outcomes (death, myocardial infarction, heart failure, length of stay).

Conclusions:

  • Diabetic and non-diabetic patients with unstable angina exhibit comparable inflammatory activity.
  • The increase in acute-phase proteins during UA appears to be independent of the patient's metabolic state (diabetic or non-diabetic).
  • Inflammatory activity differences do not seem to be the primary driver of worse prognosis in diabetic UA patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...